SDX 7195
Alternative Names: SDX-7195Latest Information Update: 28 Aug 2022
At a glance
- Originator SynDevRx, Inc
- Class Drug conjugates
- Mechanism of Action Methionine aminopeptidase 2 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Metabolic disorders
Most Recent Events
- 28 Aug 2022 No recent reports of development identified for research development in Metabolic-disorders in USA
- 26 Jul 2018 Early research in Metabolic disorders in USA (unspecified route) (SynDevRx pipeline, July 2018)